1. Home
  2. SCLXW vs AGNCM Comparison

SCLXW vs AGNCM Comparison

Compare SCLXW & AGNCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

N/A

Current Price

$0.14

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Logo AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

AGNCM

AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

N/A

Current Price

$24.85

Market Cap

0.0

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLXW
AGNCM
Founded
N/A
2008
Country
United States
United States
Employees
30
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLXW
AGNCM
Price
$0.14
$24.85
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.0K
13.5K
Earning Date
03-07-2025
01-26-2026
Dividend Yield
N/A
8.91%
EPS Growth
N/A
N/A
EPS
N/A
0.70
Revenue
$55,152,000.00
$956,000,000.00
Revenue This Year
N/A
$13.57
Revenue Next Year
N/A
$57.74
P/E Ratio
N/A
$17.72
Revenue Growth
22.02
N/A
52 Week Low
$0.18
$23.01
52 Week High
$0.18
$25.49

Technical Indicators

Market Signals
Indicator
SCLXW
AGNCM
Relative Strength Index (RSI) 48.38 49.85
Support Level $0.13 $24.90
Resistance Level $0.18 $25.00
Average True Range (ATR) 0.03 0.11
MACD 0.00 0.00
Stochastic Oscillator 50.00 44.44

Price Performance

Historical Comparison
SCLXW
AGNCM

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About AGNCM AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.

Share on Social Networks: